A clinical trial to study the effect of aseptic measures on the surgical wound of repeat caesarean deliveries
Not Applicable
- Conditions
- Health Condition 1: O860- Infection of obstetric surgical wound
- Registration Number
- CTRI/2022/02/040086
- Lead Sponsor
- university college of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Pregnant women with period of gestation more than 28 weeks undergoing elective
2.repeat caesarean section not in labor.
3.History of previous one or two caesarean sections
4.Willing to follow up in UCMS & GTB Hospital.
Exclusion Criteria
1. Patients with leaking per vaginum or chorioamnionitis
2. Patients with the following high risk factors at the time of recruitment will be excluded
2a Moderate or Severe anemia
2b Gestational or pre-gestational diabetes mellitus
2c Immunocompromised patients
2d BMI >30 kg/m2
2e Smoking
3 Patients with history of surgical site infection in the previous caesarean scar.
4 Any skin condition around surgical site
5 Patients allergic to chlorhexidine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umbers of patients developing surgical site infections within 30 days after caesarean <br/ ><br>delivery, defined as superficial, deep or organ space infection according to Centers for <br/ ><br>Disease Control and Prevention(CDC) and National Healthcare Safety Network (NHSN) <br/ ><br>in both the groups.Timepoint: At Day 3 <br/ ><br>At Day 14 <br/ ><br>At Day 21 <br/ ><br>At Day 30
- Secondary Outcome Measures
Name Time Method ength of hospital stay (in days) in both groupsTimepoint: at time of discharge;Number of patients having adverse effect of bundle componentsTimepoint: at baseline;Number of patients undergoing resuturing in both groupsTimepoint: within 30 days;Organism isolated in pus cultureTimepoint: at time of infection